Zhengguo Hu
Overview
    Explore the profile of Zhengguo Hu including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              13
            
            
              Citations
              163
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Lang X, Hu Z, Zhao Z, Zhou K, Xu Z, Li M, et al.
  
  
    Phys Med Biol
    . 2023 Dec;
          69(2).
    
    PMID: 38064745
  
  
          The FLASH effect of carbon ion therapy has recently attracted significant attention from the scientific community. However, the radiobiological mechanism of the effect and the exact therapeutic conditions are still...
      
2.
        
    
    Huang C, Xu Z, Zhao Z, Yin Y, Hu Z, She Q, et al.
  
  
    Appl Radiat Isot
    . 2023 Oct;
          203:111072.
    
    PMID: 37897938
  
  
          Range uncertainty in carbon ion therapy can diminish treatment efficacy because it may cause deviation from the planned dose distribution. The precise and accurate determination of relative stopping power (RSP)...
      
3.
        
    
    Si T, Ning X, Chen H, Hu Z, Dun L, Zheng N, et al.
  
  
    J Gastrointest Oncol
    . 2022 Jan;
          12(6):3079-3092.
    
    PMID: 35070431
  
  
          Background: With high incidence and mortality rates, hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors worldwide. Chronic hepatitis B virus (HBV) infection is a leading cause of...
      
4.
        
    
    Si T, Ning X, Zhao H, Zhang M, Huang P, Hu Z, et al.
  
  
    Cancer Gene Ther
    . 2020 Dec;
          28(6):706-718.
    
    PMID: 33257740
  
  
          Due to the lack of early diagnostic and effective treatment modalities, hepatocellular carcinoma (HCC) is still the most lethal cancer with a high mortality on a global scale. Recent studies...
      
5.
        
    
    Xiong Y, Xu L, Yu X, Yang Y, Zhao D, Hu Z, et al.
  
  
    Spine (Phila Pa 1976)
    . 2018 Mar;
          43(20):1418-1425.
    
    PMID: 29547460
  
  
          Study Design: A retrospective study. Objective: To compare the mid-term outcomes of hybrid surgery (HS) and anterior cervical discectomy and fusion (ACDF) for the treatment of contiguous two-segment cervical degenerative...
      
6.
        
    
    Ji Z, Hu Z, Xu Y
  
  
    Int J Clin Exp Pathol
    . 2015 Aug;
          8(6):6764-71.
    
    PMID: 26261560
  
  
          APPL1, an intracellular adaptor protein, takes part in numerous metabolic reactions. Although APPL1 plays a key role in glucose metabolism via adiponectin pathway and has been proved associated with type...
      
7.
        
    
    Wang Z, Xu M, Hu Z, Shrestha U
  
  
    Menopause
    . 2014 Dec;
          22(6):667-73.
    
    PMID: 25513983
  
  
          Objective: This study aims to investigate the prevalence of nonalcoholic fatty liver disease (NAFLD), to determine the metabolic risk factors of this disease, and to predict nonalcoholic steatohepatitis (NASH) with...
      
8.
        
    
    Wang Z, Xu M, Hu Z, Hultstrom M, Lai E
  
  
    Eur J Gastroenterol Hepatol
    . 2014 Jul;
          26(9):1015-21.
    
    PMID: 25003744
  
  
          Background: This study aimed to investigate the sex-specific prevalence and metabolic risk factors of fatty liver disease (FLD), and to predict the prevalence of steatohepatitis with liver fibrosis in Wuhan,...
      
9.
        
    
    Wang Z, Xu M, Peng J, Jiang L, Hu Z, Wang H, et al.
  
  
    Exp Gerontol
    . 2013 Jun;
          48(8):705-9.
    
    PMID: 23721951
  
  
          Objective: The aim of this study was to investigate the metabolic risk factors for fatty liver disease in the elderly, and determine the prevalence of fatty liver disease in the...
      
10.
        
    
    Chen M, Xia B, Chen B, Guo Q, Li J, Ye M, et al.
  
  
    Can J Gastroenterol
    . 2007 Mar;
          21(3):155-8.
    
    PMID: 17377643
  
  
          Aim: N-acetyltransferase 2 (NAT2) is an important enzyme catalyzing N-acetylation of sulfasalazine (SASP). The aim of the present study was to investigate associations of the genotypes of NAT2 with inflammatory...